A bacteriophages journey through the human body

Immunological Reviews

Volumn 279, Issue 1, 2017, Pages 106-122

  Barr, Jeremy J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

immune system; microbiome; mucus barrier; tolerance; virus

Indexed keywords

ART; BACTERIAL COLONIZATION; BACTERIAL IMMUNITY; BACTERIAL TRANSMISSION; BACTERIOPHAGE; CELL LAYER; CELL ORGANELLE; HOST; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; MICROBIAL COMMUNITY; MICROFLORA; MUCOSA; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; BACTERIUM; HOMEOSTASIS; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; VIROLOGY;

ANIMALS; BACTERIA; BACTERIOPHAGES; HOMEOSTASIS; HUMAN BODY; HUMANS; IMMUNE SYSTEM; INTESTINES; MICROBIOTA; MUCOUS MEMBRANE;

EID: 85028527074     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/imr.12565     Document Type: Review

References (247)

1. Edwards RA, Rohwer F. Opinion: Viral metagenomics. Nat Rev Microbiol. 2005;3:504-510.
2. Hendrix RW, Smith MC, Burns RN, Ford ME, Hatfull GF. Evolutionary relationships among diverse bacteriophages and prophages: all the world's a phage. Proc Natl Acad Sci USA. 1999;96:2192-2197.
3. Dutilh BE. Metagenomic ventures into outer sequence space. Bacteriophage. 2014;4:e979664.
4. Youle M, Haynes M, Rohwer FL. Scratching the Surface of Biology's Dark Matter. Dordrecht: Springer; 2012.
5. Costello EK, Lauber CL, Hamady M, Fierer N, Gordon JI, Knight R. Bacterial community variation in human body habitats across space and time. Science. 2009;326:1694-1697.
6. Sender R, Fuchs S, Milo R, et al. Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell. 2016;164:337-340.
7. Marchesi J, Shanahan F. The normal intestinal microbiota. Curr Opin Infect Dis. 2007;20:508-513.
8. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science. 2012;336:1268-1273.
9. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457:480-484.
10. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis. 2009;41:850-853.
11. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: An integrative view. Cell. 2012;148:1258-1270.
12. Reiff C, Kelly D. Inflammatory bowel disease, gut bacteria and probiotic therapy. Int J Med Microbiol. 2010;300:25-33.
13. Quigley EMM. Prebiotics and probiotics; modifying and mining the microbiota. Pharmacol Res. 2010;61:213-218.
14. Sarker SA, Sultana S, Reuteler G, et al. Oral phage therapy of acute bacterial diarrhea with two coliphage preparations: A randomized trial in children from Bangladesh. EBioMedicine. 2016;4:124-137.
15. Deuring JJ, de Haar C, Kuipers EJ, Peppelenbosch MP, van der Woude CJ. The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease. Int J Biochem Cell Biol. 2013;45:798-806.
16. Breitbart M, Hewson I, Felts B, et al. Metagenomic analyses of an uncultured viral community from human feces. J Bacteriol. 2003;185:6220-6223.
17. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature. 2010;466:334-338.
18. Minot S, Sinha R, Chen J, et al. The human gut virome: Inter-individual variation and dynamic response to diet. Genome Res. 2011;21:1616-1625.
19. Dabrowska K, Switała-Jelen K, Opolski A, Weber-Dabrowska B, Gorski A. Bacteriophage penetration in vertebrates. J Appl Microbiol. 2005;98:7-13.
20. Merril CR. Bacteriophage interactions with higher organisms. Trans N Y Acad Sci. 1974;36:265-272.
21. Dubos RJ, Straus JH, Pierce C. The multiplication of bacteriophage in vivo and its protective effect against an experimental infection with Shigella dyenteriae. J Exp Med. 1943;78:161-168.
22. D'Herelle F, d'Hérelle F. The Bacteriophage: Its Role in Immunity. Vol. 2. France: Masson; 1921.
23. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010;107:11971-11975.
24. Scholtens P, Oozeer R, Martin R, Amor KB, Knol J. The early settlers: Intestinal microbiology in early life. Annu Rev Food Sci Technol. 2012;3:425-447.
25. Costello EK, Stagaman K, Dethlefsen L, Bohannan BJM, Relman DA. The application of ecological theory toward an understanding of the human microbiome. Science. 2012;336:1255-1262.
26. Oh J, Byrd AL, Park M, Kong HH, Segre JA. Temporal stability of the human skin microbiome. Cell. 2016;165:854-866.
27. Foulongne V, Sauvage V, Hebert C, et al. Human skin microbiota: High diversity of DNA viruses identified on the human skin by high throughput sequencing. PLoS ONE. 2012;7:e38499.
28. Pride DT, Salzman J, Haynes M, et al. Evidence of a robust resident bacteriophage population revealed through analysis of the human salivary virome. ISME J. 2012;6:915-926.
29. Wang J, Gao Y, Zhao F. Phage–bacteria interaction network in human oral microbiome. Environ Micro. 2015;18:2143-2158.
30. Lim YW, Schmieder R, Haynes M, et al. Metagenomics and metatranscriptomics: Windows on CF-associated viral and microbial communities. J Cyst Fibros. 2012;12:154-164.
31. Dickson RP, Huffnagle GB. The lung microbiome: New principles for respiratory bacteriology in health and disease. PLoS Pathog. 2015;11:e1004923.
32. Santiago-Rodriguez TM, Ly M, Bonilla N, Pride DT. The human urine virome in association with urinary tract infections. Front Microbiol. 2015;6:14.
33. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol. 1977;31:107-133.
34. Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1:31-45.
35. Kim MS, Park E-J, Roh SW, Bae JW. Diversity and abundance of single-stranded DNA viruses in human feces. Appl Environ Microbiol. 2011;77:8062-8070.
36. Reyes A, Wu M, McNulty NP, Rohwer FL, Gordon JI. Gnotobiotic mouse model of phage-bacterial host dynamics in the human gut. Proc Natl Acad Sci USA. 2013;110:20236-20241.
37. Ackermann HW, DuBow M. General Properties of Bacteriophages. Viruses of Prokaryotes. Boca Raton, FL: CRC Press; 1987.
38. Hobbs Z, Abedon ST. Diversity of phage infection types and associated terminology: The problem with “Lytic or lysogenic”. FEMS Microbiol Lett. 2016;363:fnw047.
39. Mills S, Shanahan F, Stanton C, Hill C, Coffey A, Ross RP. Movers and shakers: Influence of bacteriophages in shaping the mammalian gut microbiota. Gut Microbes. 2013;4:4-16.
40. Duerkop BA, Clements CV, Rollins D, Rodrigues JLM, Hooper LV. A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci USA. 2012;109:17621-17626.
41. Obeng N, Pratama AA, van Elsas JD. The significance of mutualistic phages for bacterial ecology and evolution. Trends Microbiol. 2016;24:440-449.
42. Barr JJ, Youle M, Rohwer F. Innate and acquired bacteriophage-mediated immunity. Bacteriophage. 2013;3:10771-10776.
43. Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. Rapid evolution of the human gut virome. Proc Natl Acad Sci USA. 2013;110:12450-12455.
44. Thingstad TF, Lignell R. Theoretical models for the control of bacterial growth rate, abundance, diversity and carbon demand. Aquat Microb Ecol. 1997;13:19-27.
45. Rodriguez-Brito B, Li L, Wegley L, et al. Viral and microbial community dynamics in four aquatic environments. ISME J. 2010;4:739-751.
46. Me J, Payet P, Suttle CA. To kill or not to kill: The balance between lytic and lysogenic viral infection is driven by trophic status. Limnol Oceanogr. 2013;58:465-474.
47. Knowles B, Silveira CB, Bailey BA, et al. Lytic to temperate switching of viral communities. Nature. 2016;531:466-470.
48. Silveira CB, Rohwer FL. Piggyback-the-Winner in host-associated microbial communities. NPJ Biofilms Microbiomes. 2016;2:16010.
49. Ogilvie LA, Jones BV. The human gut virome: A multifaceted majority. Front Microbiol. 2015;6:918.
50. Manrique P, Bolduc B, Walk ST, van der Oost J, de Vos WM, Young MJ. Healthy human gut phageome. Proc Natl Acad Sci USA. 2016;113:10400-10405.
51. Barr JJ, Auro R, Furlan M, et al. Bacteriophage adhering to mucus provide a non-host-derived immunity. Proc Natl Acad Sci USA. 2013;110:10771-10776.
52. Roossinck MJ. The good viruses: Viral mutualistic symbioses. Nat Rev Microbiol. 2011;9:99-108.
53. Dutilh BE, Cassman N, McNair K, et al. A highly abundant bacteriophage discovered in the unknown sequences of human faecal metagenomes. Nat Commun. 2014;5:1-11.
54. Norman JM, Handley SA, Baldridge MT, et al. Disease-specific alterations in the enteric virome in inflammatory bowel disease. Cell. 2015;160:447-460.
55. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464:59-65.
56. Huttenhower C, Gevers D, Knight R, et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012;486:207-214.
57. Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science. 2013;341:1237439.
58. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature. 2012;486:222.
59. Kim M-S, Bae J-W. Spatial disturbances in altered mucosal and luminal gut viromes of diet-induced obese mice. Environ Micro. 2016;1:1498-1510.
60. Reyes A, Blanton LV, Cao S, et al. Gut DNA viromes of Malawian twins discordant for severe acute malnutrition. Proc Natl Acad Sci USA. 2015;112:11941-11946.
61. Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu Rev Nutr. 2002;22:283-307.
62. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA. 2002;99:15451-15455.
63. Bäckhed F, Ding H, Wang T, et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. 2004;101:15718-15723.
64. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med. 2009;1:6ra14.
65. Weiss M, Denou E, Bruttin A, Serra-Moreno R, Dillmann M-L, Brüssow H. In vivo replication of T4 and T7 bacteriophages in germ-free mice colonized with Escherichia coli. Virology. 2009;393:16-23.
66. Seok J, Warren HS, Cuenca AG, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci USA. 2013;110:3507-3512.
67. Burkhardt AM, Zlotnik A. Translating translational research: Mouse models of human disease. Cell Mol Immunol. 2013;10:373-374.
68. Arrieta M-C, Walter J, Finlay BB, et al. Human microbiota-associated mice: A model with challenges. Cell Host Microbe. 2016;19:575-578.
69. Huh D, Kim HJ, Fraser JP, et al. Microfabrication of human organs-on-chips. Nat Protoc. 2013;8:2135-2157.
70. Huh D, Matthews BD, Mammoto A, Montoya-Zavala M, Hsin HY, Ingber DE. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662-1668.
71. Kim HJ, Huh D, Hamilton G, Ingber DE. Human Gut-on-a-Chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12:2165-2174.
72. Barr JJ, Auro R, Sam-Soon N, et al. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters. Proc Natl Acad Sci USA. 2015;112:201508355.
73. Cone RA. Barrier properties of mucus. Adv Drug Deliv Rev. 2009;61:75-85.
74. Linden SK, Sutton P, Karlsson NG, Korolik V, McGuckin MA. Mucins in the mucosal barrier to infection. Mucosal Immunol. 2008;1:183-197.
75. Johansson MEV, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA. 2008;105:15064-15069.
76. Johansson MEV, Larsson JMH, Hansson GC. The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc Natl Acad Sci USA. 2011;108:4659-4665.
77. Bäckhed F, Ley RE, Sonnenburg JL, Peterson DA, Gordon JI. Host-bacterial mutualism in the human intestine. Science. 2005;307:1915-1920.
78. Martens EC, Chiang HC, Gordon JI. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe. 2008;4:447-457.
79. Donaldson GP, Lee SM, Mazmanian SK. Gut biogeography of the bacterial microbiota. Nat Rev Microbiol. 2015;14:20-32.
80. Nguyen-Kim H, Bettarel Y, Bouvier T, et al. Coral mucus is a hot spot of viral infections. Appl Environ Microbiol. 2015;81:5773-5783.
81. Nguyen-Kim H, Bouvier T, Bouvier C, et al. High occurrence of viruses in the mucus layer of scleractinian corals. Environ Microbiol Rep. 2014;6:675-682.
82. Rose MC, Voynow JA. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol Rev. 2006;245–278.
83. Johansson MEV, Hansson GC. Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol. 2016;16:639-649.
84. Minot S, Grunberg S, Wu GD, Lewis JD, Bushman FD. Hypervariable loci in the human gut virome. Proc Natl Acad Sci USA. 2012;109:3962-3966.
85. Bork P, Holm L, Sander C. The immunoglobulin fold: Structural classification, sequence patterns and common core. J Mol Biol. 1994;242:309-320.
86. Bateman A, Eddy SR, Mesyanzhinov VV. A member of the immunoglobulin superfamily in bacteriophage T4. Virus Genes. 1997;14:163-165.
87. Davies DR, Padlan EA, Segal DM. Three-dimensional structure of immunoglobulins. Annu Rev Biochem. 1975;44:639-667.
88. Fraser JS, Yu Z, Maxwell KL, Davidson AR. Ig-like domains on bacteriophages: A tale of promiscuity and deceit. J Mol Biol. 2006;359:496-507.
89. Katsura I. Structure and function of the major tail protein of bacteriophage lambda: Mutants having small major tail protein molecules in their virion. J Mol Biol. 1981;146:493-512.
90. Fraser JS, Maxwell KL, Davidson AR. Immunoglobulin-like domains on bacteriophage: Weapons of modest damage? Curr Opin Microbiol. 2007;10:382-387.
91. Fokine A, Islam MZ, Zhang Z, Bowman VD, Rao VB, Rossmann MG. Structure of the three N-terminal immunoglobulin domains of the highly immunogenic outer capsid protein from a T4-like bacteriophage. J Virol. 2011;85:8141-8148.
92. Sathaliyawala T, Islam MZ, Li Q, Fokine A, Rossmann MG, Rao VB. Functional analysis of the highly antigenic outer capsid protein, Hoc, a virus decoration protein from T4-like bacteriophages. Mol Microbiol. 2010;77:444-455.
93. Gorski A, Borysowski J, Miedzybrodzki R, Weber-Dąbrowska B. Bacteriophages in Medicine. Norfolk: Caister; 2007.
94. Dabrowska K, Opolski A, Wietrzyk J, et al. Anticancer activity of bacteriophage T4 and its mutant HAP1 in mouse experimental tumour models. Anticancer Res. 2004;24:3991-3995.
95. Alymova IV, Portner A, Mishin VP, McCullers JA, Freiden P, Taylor GL. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology. 2012;22:174-180.
96. Garrido D, Kim JH, German JB, Raybould HE, Mills DA. Oligosaccharide binding proteins from Bifidobacterium longum subsp. infantis reveal a preference for host glycans. PLoS ONE. 2011;6:e17315.
97. Mello LV, Chen X, Rigden DJ. Mining metagenomic data for novel domains: BACON, a new carbohydrate-binding module. FEBS Lett. 2010;584:2421-2426.
98. Lai SK, Wang Y-Y, Wirtz D, Hanes J. Micro- and macrorheology of mucus. Adv Drug Deliv Rev. 2009;61:86-100.
99. Hill DB, Vasquez PA, Mellnik J, et al. A biophysical basis for mucus solids concentration as a candidate biomarker for airways disease. PLoS ONE. 2014;9:e87681.
100. Boegh M, García-Díaz M, Müllertz A, Nielsen HM. Steric and interactive barrier properties of intestinal mucus elucidated by particle diffusion and peptide permeation. Eur J Pharm Biopharm. 2015;95:136-143.
101. Humphries NE, Weimerskirch H, Queiroz N, Southall EJ, Sims DW. Foraging success of biological Lévy flights recorded in situ. Proc Natl Acad Sci USA. 2012;109:7169-7174.
102. Schuster FL, Levandowsky M. Chemosensory responses of Acanthamoeba castellanii: Visual analysis of random movement and responses to chemical signals. J Eukaryot Microbiol. 1996;43:150-158.
103. Raichlen DA, Wood BM, Gordon AD, Mabulla AZP, Marlowe FW, Pontzer H. Evidence of Levy walk foraging patterns in human hunter-gatherers. Proc Natl Acad Sci USA. 2014;111:728-733.
104. Viswanathan GM, Afanasyev V, Buldyrev SV, Murphy EJ, Prince PA, Stanley HE. Lévy flight search patterns of wandering albatrosses. Nature. 1996;381:413.
105. Brüssow H. Bacteriophage-host interaction: From splendid isolation into a messy reality. Curr Opin Microbiol. 2013;16:500-506.
106. Brüssow H. What is needed for phage therapy to become a reality in Western medicine? Virology. 2012;434:138-142.
107. Relman DA. The human microbiome: Ecosystem resilience and health. Nutr Rev. 2012;70:2-9.
108. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220-230.
109. Schluter J, Foster KR. The Evolution of Mutualism in Gut Microbiota Via Host Epithelial Selection. PLoS Biol. 2012;10:e1001424.
110. Chibani-Chennoufi S, Sidoti J, Bruttin A, Kutter E, Sarker S, Brüssow H. In vitro and in vivo bacteriolytic activities of Escherichia coli phages: Implications for phage therapy. Antimicrob Agents Chemother. 2004;48:2558-2569.
111. Chibani-Chennoufi S, Bruttin A, Dillmann M-L, Brüssow H. Phage-host interaction: An ecological perspective. J Bacteriol. 2004;186:3677-3686.
112. Poulsen LK, Lan F, Kristensen CS, Hobolth P, Molin S, Krogfelt KA. Spatial distribution of Escherichia coli in the mouse large intestine inferred from rRNA in situ hybridization. Infect Immun. 1994;62:5191-5194.
113. Poulsen LK, Licht TR, Rang C, Krogfelt KA, Molin S. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol. 1995;177:5840-5845.
114. Wiggins BA, Alexander M. Minimum bacterial density for bacteriophage replication: Implications for significance of bacteriophages in natural ecosystems. Appl Envir Microbiol. 1985;49:19-23.
115. Taniuchi M, Sobuz SU, Begum S, et al. Etiology of diarrhea in Bangladeshi infants in the first year of life analyzed using molecular methods. J Infect Dis. 2013;208:1794-1802.
116. Kotloff KL, Nataro JP, Blackwelder WC, et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): A prospective, case-control study. Lancet. 2013;382:209-222.
117. Thomsson KA, Holmén-Larsson JM, Angström J, Johansson ME, Xia L, Hansson GC. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2. Glycobiology. 2012;22:1128-1139.
118. Hattrup CL, Gendler SJ. Structure and function of the cell surface (tethered) mucins. Annu Rev Physiol. 2008;70:431-457.
119. Pelaseyed T, Bergström JH, Gustafsson JK, et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system. Immunol Rev. 2014;260:8-20.
120. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol. 2006;16:467-476.
121. Carraway KL, Ramsauer VP, Haq B, Carothers Carraway CA. Cell signaling through membrane mucins. BioEssays. 2003;25:66-71.
122. Rahn JJ, Shen Q, Mah BK, Hugh JC. MUC1 initiates a calcium signal after ligation by intercellular adhesion molecule-1. J Biol Chem. 2004;279:29386-29390.
123. Pelaseyed T, Hansson GC. CFTR anion channel modulates expression of human transmembrane mucin MUC3 through the PDZ protein GOPC. J Cell Sci. 2011;124:3074-3083.
124. Sheng YH, Lourie R, Lindén SK, et al. The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut. 2011;60:1661-1670.
125. Bafna S, Kaur S, Batra SK. Membrane-bound mucins: The mechanistic basis for alterations in the growth and survival of cancer cells. Oncogene. 2010;29:2893-2904.
126. Govindarajan B, Gipson IK. Membrane-tethered mucins have multiple functions on the ocular surface. Exp Eye Res. 2010;90:655-663.
127. Lillehoj EP, Kim H, Chun EY, Kim KC. Pseudomonas aeruginosa stimulates phosphorylation of the airway epithelial membrane glycoprotein Muc1 and activates MAP kinase. Am J Physiol Lung Cell Mol Physiol. 2004;287:809-815.
128. Lillehoj EP, Kim BT, Kim KC. Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin. Am J Physiol Lung Cell Mol Physiol. 2002;282:751-756.
129. Bloch H. Experimental investigation on the relationship between bacteriophages and maligant tumors. Adv Virol. 1940;1:481-496.
130. Dabrowska K, Opolski A, Wietrzyk J, et al. Antitumor activity of bacteriophages in murine experimental cancer models caused possibly by inhibition of beta3 integrin signaling pathway. Acta Virol. 2004;48:241-248.
131. Dabrowska K, Zembala M, Boratynski J, et al. Hoc protein regulates the biological effects of T4 phage in mammals. Arch Microbiol. 2007;187:489-498.
132. Talago N, Natasha T. Bacteriophage Interactions within the Human Mucosal Immune System. San Diego, CA: Diss. San Diego State University; 2015.
133. Keller R, Engley FB. Fate of bacteriophage particles introduced into mice by various routes. Proc Soc Exp Biol Med. 1958;98:577-580.
134. Geier MR, Trigg ME, Merril CR. Fate of bacteriophage lambda in non-immune germ-free mice. Nature. 1973;246:221-223.
135. Hildebrand GJ, Wolochow H. Translocation of bacteriophage across the intestinal wall of the rat. Proc Soc Exp Biol Med. 1962;109:183-185.
136. Hoffman M. Animal experiments on mucosal passage and absorption viraemia of T3 phages after oral, trachéal and rectal administration. Zentralbl Bakteriol Orig. 1965;198:371-390.
137. Bogovazova GG, Voroshilova NN, Bondarenko VM. The efficacy of Klebsiella pneumoniae bacteriophage in the therapy of experimental Klebsiella infection. Zh Mikrobiol Epidemiol Immunobiol. 1991;5–8.
138. Slopek S, Weber-Dabrowska B, Dabrowski M, Kucharewicz-Krukowska A. Results of bacteriophage treatment of suppurative bacterial infections in the years 1981-1986. Arch Immunol Ther Exp. 1987;35:569-583.
139. Weber-Dabrowska B, Dabrowski M, Slopek S. Studies on bacteriophage penetration in patients subjected to phage therapy. Arch Immunol Ther Exp. 1987;35:563-568.
140. Merril CR, Friedman TB, Attallah AFM, Geier MR, Krell K, Yarkin R. Isolation of bacteriophages from commercial sera. In Vitro. 1972;8:91-93.
141. Chu FC, Johnson JB, Orr HC, Probst PG, Petricciani JC. Bacterial virus contamination of fetal bovine sera. In Vitro. 1973;9:31-34.
142. Handley SA, Thackray LB, Zhao G, et al. Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome. Cell. 2012;151:253-266.
143. Karimi M, Mirshekari H, Moosavi Basri SM, Bahrami S, Moghoofei M, Hamblin MR. Bacteriophages and phage-inspired nanocarriers for targeted delivery of therapeutic cargos. Adv Drug Deliv Rev. 2016;106:45-62.
144. Hsia R, Ohayon H, Gounon P, Dautry-Varsat A, Bavoil PM. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain Guinea Pig Inclusion Conjunctivitis. Microbes Infect. 2000;2:761-772.
145. Johnston N. Viral Trojan horse for combating tuberculosis. Drug Discov Today. 2002;7:333-335.
146. Nieth A, Verseux C, Römer W. A question of attire: Dressing up bacteriophage therapy for the battle against antibiotic-resistant intracellular bacteria. Springer Sci Rev. 2014;3:1-11.
147. Duerkop BA, Hooper LV. Resident viruses and their interactions with the immune system. Nat Immunol. 2013;14:654-659.
148. Ivanenkov VV, Menon AG. Peptide-mediated transcytosis of phage display vectors in MDCK cells. Biochem Biophys Res Comm. 2000;276:251-257.
149. Larocca D, Burg MA, Jensen-Pergakes K, Ravey EP, Gonzalez AM, Baird A. Evolving phage vectors for cell targeted gene delivery. Curr Pharm Biotechnol. 2002;3:45-57.
150. Pranjol MZI, Hajitou A. Bacteriophage-derived vectors for targeted cancer gene therapy. Viruses. 2015;7:268-284.
151. Bakhshinejad B, Karimi M, Sadeghizadeh M. Bacteriophages and medical oncology: Targeted gene therapy of cancer. Med Oncol. 2014;31:110.
152. Tian Y, Wu M, Liu X, et al. Probing the endocytic pathways of the filamentous bacteriophage in live cells using ratiometric pH fluorescent indicator. Adv Healthc Mater. 2015;4:413-419.
153. Tao P, Mahalingam M, Marasa BS, Zhang Z, Chopra AK, Rao VB. In vitro and in vivo delivery of genes and proteins using the bacteriophage T4 DNA packaging machine. Proc Natl Acad Sci USA. 2013;110:5846-5851.
154. Aronow R, Danon D, Shahar A, Aronson M. Electron microscopy of in vitro endocytosis of T2 phage by cells from rabbit perioneal exudate. J Exp Med. 1964;120:943-954.
155. Zhang L, Sun L, Wei R, et al. Study of intracellular Staphylococcus aureus control by virulent bacteriophage within MAC-T bovine mammary epithelial cells. Antimicrob Agents Chemother. 2016;61:e01990-16.
156. Kaźmierczak Z, Piotrowicz A, Owczarek B, et al. Molecular imaging of T4 phage in mammalian tissues and cells. Bacteriophage. 2014;4:e28364.
157. Górski A, Wazna E, Dabrowska B-W, Dabrowska K, Switała-Jeleń K, Miedzybrodzki R. Bacteriophage translocation. FEMS Immunol Med Microbiol. 2006;46:313-319.
158. Medzhitov R, Janeway CA. Decoding the patterns of self and nonself by the innate immune system. Science. 2002;296:298-300.
159. Randow F, MacMicking JD, James LC. Cellular self-defense: How cell-autonomous immunity protects against pathogens. Science. 2013;340:701-706.
160. Tam JCH, Jacques DA. Intracellular immunity: Finding the enemy within–how cells recognize and respond to intracellular pathogens. J Leukoc Biol. 2014;96:233-244.
161. Kaur T, Nafissi N, Wasfi O, Sheldon K, Wettig S, Slavcev R. Immunocompatibility of bacteriophages as nanomedicines. J. Nanotechnol. 2012;2012:1-13.
162. Paepe MD, Leclerc M, Tinsley CR, Petit M-A. Bacteriophages: An underestimated role in human and animal health? Front Cell Infect Microbiol. 2014;4:39.
163. Shutt TE, Gray MW. Bacteriophage origins of mitochondrial replication and transcription proteins. Trends Genet. 2006;22:90-95.
164. Filée J, Forterre P, Sen-Lin T, Laurent J. Evolution of DNA polymerase families: Evidences for multiple gene exchange between cellular and viral proteins. J Mol Evol. 2002;54:763-773.
165. Chan Y-W, Mohr R, Millard AD, et al. Discovery of cyanophage genomes which contain mitochondrial DNA polymerase. Mol Biol Evol. 2011;28:2269-2274.
166. Bordenstein SR, Bordenstein SR. Eukaryotic association module in phage WO genomes from Wolbachia. Nat Commun. 2016;7:504-510.
167. Merril CR, Geier MR, Petricciani JC. Bacterial virus gene expression in human cells. Nature. 1971;233:398-400.
168. Geier MR, Merril CR. Lambda phage transcription in human fibroblasts. Virology. 1972;47:638-643.
169. Lankes HA, Zanghi CN, Santos K, Capella C, Duke CMP, Dewhurst S. In vivo gene delivery and expression by bacteriophage lambda vectors. J Appl Microbiol. 2007;102:1337-1349.
170. Wenger SL, Steele MW, Turner JH. Incorporation of bacteriophage DNA into the genome of cultured human lymphocytes. In Vitro. 1981;17:695-700.
171. Poul MA, Marks JD. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol. 1999;288:203-211.
172. Carrera MRA, Kaufmann GF, Mee JM, Meijler MM, Koob GF, Janda KD. Treating cocaine addiction with viruses. Proc Natl Acad Sci USA. 2004;101:10416-10421.
173. Modi SR, Lee HH, Spina CS, Collins JJ. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature. 2013;499:219-222.
174. Fancello L, Monteil S, Popgeorgiev N, et al. Viral communities associated with human pericardial fluids in idiopathic pericarditis. PLoS ONE. 2014;9:e93367.
175. Breitbart M, Rohwer F. Method for discovering novel DNA viruses in blood using viral particle selection and shotgun sequencing. Biotechniques. 2005;39:279.
176. Frenkel D, Solomon B. Filamentous phage as vector-mediated antibody delivery to the brain. Proc Natl Acad Sci USA. 2002;99:5675-5679.
177. Dinakaran V, Rathinavel A, Pushpanathan M, et al. Elevated levels of circulating DNA in cardiovascular disease patients: Metagenomic profiling of microbiome in the circulation. PLoS ONE. 2014;9:e105221.
178. Thannesberger J, Hellinger H-J, Klymiuk I, et al. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples. FASEB J. 2017;31:1987-2000.
179. Kowarsky MA, Camunas-Soler J, Kertesz M, et al. Humans are colonized by many uncharacterized and highly divergent microbes. BioRxiv. 2017;113746:1-41.
180. Haynes M, Rohwer F. The Human Virome. In: Nelson KE, ed. Metagenomics of the Human Body. New York, NY: Springer; 2011:63-77.
181. Wiig H, Keskin D, Kalluri R. Interaction between the extracellular matrix and lymphatics: Consequences for lymphangiogenesis and lymphatic function. Matrix Biol. 2010;29:645-656.
182. Choi I, Lee S, Hong Y-K. The new era of the lymphatic system: No longer secondary to the blood vascular system. Cold Spring Harb Perspect Med. 2012;2:a006445.
183. Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA. 1996;93:3188-3192.
184. Hodyra-Stefaniak K, Miernikiewicz P, Drapała J, et al. Mammalian host-versus-phage immune response determines phage fate in vivo. Sci Rep. 2015;5:14802.
185. Majewska J, Beta W, Lecion D, et al. Oral application of T4 phage induces weak antibody production in the gut and in the blood. Viruses. 2015;7:4783-4799.
186. Stecher B, Hardt W-D. The role of microbiota in infectious disease. Trends Microbiol. 2008;16:107-114.
187. Pham TAN, Clare S, Goulding D, et al. Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe. 2014;16:504-516.
188. Gorski A, Międzybrodzki R, Borysowski J, et al. Phage as a modulator of immune responses: Practical implications for phage therapy. Adv Virus Res. 2012;83:41.
189. Dabrowska K, Switała-Jeleń K, Opolski A, Górski A. Possible association between phages, Hoc protein, and the immune system. Adv Virol. 2006;151:209-215.
190. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage. 2011;1:66-85.
191. Sarker SA, McCallin S, Barretto C, et al. Oral T4-like phage cocktail application to healthy adult volunteers from Bangladesh. Virology. 2012;434:222-232.
192. Quistad SD, Grasis JA, Barr JJ, Rohwer FL. Viruses and the origin of microbiome selection and immunity. ISME J. 2016;11:835-840.
193. Górski A, Kniotek M, Perkowska-Ptasińska A, et al. Bacteriophages and transplantation tolerance. Transplant Proc. 2006;38:331-333.
194. Gorski A, Nowaczyk M, Weber-Dabrowska B, et al. New insights into the possible role of bacteriophages in transplantation. Transplant Proc. 2003;35:2372-2373.
195. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol. 1995;155:1151-1164.
196. Bluestone JA, Abbas AK. Regulatory lymphocytes: Natural versus adaptive regulatory T cells. Nat Rev Immunol. 2003;3:253-257.
197. Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775-787.
198. Samy ET, Parker LA, Sharp CP, Tung KSK. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J Exp Med. 2005;202:771-781.
199. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002;420:502-507.
200. Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol. 2005;6:353-360.
201. Su LF, Alcazar DD, Stelekati E, et al. Antigen exposure shapes the ratio between antigen-specific Tregs and conventional T cells in human peripheral blood. Proc Natl Acad Sci USA. 2016;113:6192-6198.
202. Klein L, Khazaie K, von Boehmer H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc Natl Acad Sci USA. 2003;100:8886-8891.
203. Yamazaki S, Iyoda T, Tarbell K, et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med. 2003;198:235-247.
204. Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science. 2003;299:1033-1036.
205. Serra P, Amrani A, Yamanouchi J, Han B, Thiessen S. CD40 ligation releases immature dendritic cells from the control of regulatory CD4+ CD25+ T cells. Immunity. 2003;19:877-889.
206. Kaser A, Blumberg RS. Endoplasmic reticulum stress in the intestinal epithelium and inflammatory bowel disease. Semin Immunol. 2009;21:156-163.
207. Kaser A, Martínez-Naves E, Blumberg RS. Endoplasmic reticulum stress: Implications for inflammatory bowel disease pathogenesis. Curr Opin Gastroenterol. 2010;26:318-326.
208. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298-306.
209. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 1991;325:928-937.
210. Funkhouser LJ, Bordenstein SR, Gill S, et al. Mom knows best: The universality of maternal microbial transmission. PLoS Biol. 2013;11:e1001631.
211. Yong E. I Contain Multitudes: The Microbes within Us and a Grander View of Life. New York, NY: Harper Collins; 2016.
212. Wilkinson CR. Immunological evidence for the precambrian origin of bacterial symbioses in marine sponges. Proc R Soc London B Biol Sci. 1984;220:509-518.
213. Kaltenpoth M, Göttler W, Herzner G, et al. Symbiotic bacteria protect wasp larvae from fungal infestation. Curr Biol. 2005;15:475-479.
214. AlKindi AYA, Mahmoud IY, Woller MJ, Plude JL. Oviductal morphology in relation to hormonal levels in the snapping turtle, Chelydra serpentina. Tissue Cell. 2006;38:19-33.
215. Jiménez E, Fernández L, Marín ML, et al. Isolation of commensal bacteria from umbilical cord blood of healthy neonates born by cesarean section. Curr Microbiol. 2005;51:270-274.
216. DiGiulio DB, Romero R, Amogan HP, et al. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: A molecular and culture-based investigation. PLoS ONE. 2008;3:e3056.
217. Collado MC, Rautava S, Aakko J, Isolauri E, Salminen S. Human gut colonisation may be initiated in utero by distinct microbial communities in the placenta and amniotic fluid. Sci Rep. 2016;6:23129.
218. Jiménez E, Marín ML, Martín R, et al. Is meconium from healthy newborns actually sterile? Res Microbiol. 2008;159:187-193.
219. Fernández L, Langa S, Martín V, et al. The human milk microbiota: Origin and potential roles in health and disease. Pharmacol Res. 2013;69:1-10.
220. Hinde K, German JB. Food in an evolutionary context: Insights from mother's milk. J Sci Food Agric. 2012;92:2219-2223.
221. Martín R, Langa S, Reviriego C, et al. Human milk is a source of lactic acid bacteria for the infant gut. J Pediatr. 2003;143:754-758.
222. Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology. 2012;22:1147-1162.
223. Ward TL, Hosid S, Ioshikhes I, Altosaar I. Human milk metagenome: A functional capacity analysis. BMC Microbiol. 2013;13:116.
224. Jeurink PV, van Bergenhenegouwen J, Jiménez E, et al. Human milk: A source of more life than we imagine. Benef Microbes. 2013;4:17-30.
225. Ardeshir A, Narayan NR, Méndez-Lagares G, et al. Breast-fed and bottle-fed infant rhesus macaques develop distinct gut microbiotas and immune systems. Sci Transl Med. 2014;6:252ra120.
226. Urbaniak C, Cummins J, Brackstone M, et al. Microbiota of human breast tissue. Appl Environ Microbiol. 2014;80:3007-3014.
227. Ramsay DT, Kent JC, Owens RA, Hartmann PE. Ultrasound imaging of milk ejection in the breast of lactating women. Pediatrics. 2004;113:361-367.
228. Martı́n R, Langa S, Reviriego C, et al. The commensal microflora of human milk: New perspectives for food bacteriotherapy and probiotics. Trends Food Sci Technol. 2004;15:121-127.
229. Breitbart M, Haynes M, Kelley S, et al. Viral diversity and dynamics in an infant gut. Res Microbiol. 2008;159:367-373.
230. Lim ES, Zhou Y, Zhao G, et al. Early life dynamics of the human gut virome and bacterial microbiome in infants. Nat Med. 2015;21:1228-1234.
231. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA. 2011;108:4578-4585.
232. Stilling RM, Bordenstein SR, Dinan TG, Cryan JF. Friends with social benefits: Host-microbe interactions as a driver of brain evolution and development? Front Cell Infect Microbiol. 2014;4:147.
233. Mayer EA, Tillisch K, Gupta A, et al. Gut/brain axis and the microbiota. J Clin Invest. 2015;125:926-938.
234. Sampson TR, Mazmanian SK. Control of brain development, function, and behavior by the microbiome. Cell Host Microbe. 2015;17:565-576.
235. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA. 2011;108:16050-16055.
236. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155:1451-1463.
237. House PK, Vyas A, Sapolsky R, et al. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS ONE. 2011;6:e23277.
238. de Bekker C, Quevillon LE, Smith PB, et al. Species-specific ant brain manipulation by a specialized fungal parasite. BMC Evol Biol. 2014;14:166.
239. Barrow P, Lovell M, Berchieri A. Use of lytic bacteriophage for control of experimental Escherichia coli septicemia and meningitis in chickens and calves. Clin Diagn Lab Immunol. 1998;5:294-298.
240. Pardridge WM. The blood-brain barrier: Bottleneck in brain drug development. NeuroRx. 2005;2:3-14.
241. Hersh DS, Wadajkar AS, Roberts NB, et al. Evolving drug delivery strategies to overcome the blood brain barrier. Curr Pharma Des. 2016;22:1177-1193.
242. Ksendzovsky A, Walbridge S, Saunders RC, Asthagiri AR, Heiss JD, Lonser RR. Convection-enhanced delivery of M13 bacteriophage to the brain. J Neurosurg. 2012;117:197-203.
243. Thigpen MC, Whitney CG, Messonnier NE, et al. Bacterial meningitis in the United States, 1998–2007. N Engl J Med. 2011;364:2016-2025.
244. Solomon B. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment. J Alzheimer's Dis. 2008;15:193-198.
245. Messing J. Phage M13 for the treatment of Alzheimer and Parkinson disease. Gene. 2016;583:85-89.
246. Ceccaldi P-E, Fillion M-P, Ermine A, Tsiang H, Fillion G. Rabies virus selectively alters 5-HT1 receptors subtypes in rat brain. Eur J Pharmacol Mol Pharmacol. 1993;245:129-138.
247. Barr B, Crocetti G, Wild A, Barr JJ, Hutchings B. The Invisible War: A Tale on Two Scales. Melbourne: Scale Free Network; 2016.